Heather Hartnett, Katelin Holloway, Jennifer Keiser Neundorfer and Maren Thomas Bannon are involved in Elektra Health's seed funding round

From our Women's PE Briefs - week commencing August 16, 2021

Like Comment

Heather Hartnett, Katelin Holloway, Jennifer Keiser Neundorfer and Maren Thomas Bannon are involved in Elektra Health's seed funding round

Human Ventures, which is led by Heather Hartnett; Seven Seven Six’s Katelin Holloway; January Ventures, which was founded by Jennifer Keiser Neundorfer and Maren Thomas Bannon; and angel investors Hannah Raz, Claire Diaz-Ortiz and Jenny Fielding back a company co-founded by Alessandra Henderson and Jannine Versi seeking to empower women navigating menopause with evidence-based education, care and community. Elektra Health secured $3.75 million in seed funding co-led by Seven Seven Six and Flare Capital Partners, with participation from such other investors as City Light Capital, The Fund, Company Ventures, The Community Fund and angel investors including Guy Raz, Hannah’s husband.

Based in New York, Elektra is building a full-stack digital solution for menopause featuring proprietary educational programs, telemedicine care from board-certified menopause specialists and text-a-menopause-expert support.

In a statement, Katelin said, “when I heard Alessandra and Jannine’s vision to build a full-stack, integrative solution that supports women at every step of their menopause journey, I was blown away. Elektra Health is expanding digital resources to the millions of women who deserve emotional and medical support during this critical phase – investing in this company will fundamentally change how women experience menopause and eliminate the stigma associated with this phase of every woman’s life.”

Alessandra added in a statement, “menopause is finally getting the attention it deserves. Elektra has a big vision to fundamentally change the way that women experience menopause through our proprietary care model and actionable, evidence-based programs. With the backing of top investors, we’re ready to double down on our mission to smash the menopause taboo.”

QED Investors’ Lauren Morton swims into XpertSea’s $20M Series B round

QED InvestorsLauren Morton swims into a company transforming how seafood is farmed and traded – one whose co-founders include Valérie Robitaille and Sylvie Lavigne and whose board includes Aqua-Spark’s Amy Novogratz. QED and Atlantico led XpertSea’s $20 million Series B round, which also included Investissement Québec and such prior investors as Aqua-Spark, Obvious Ventures, Future Shape, Real Ventures and edō Capital.

Based in Quebec City, Quebec, XpertSea uses artificial intelligence, computer vision and machine learning to help hatcheries, farms and research centers more efficiently track and manage aquatic populations. The company is able to connect shrimp farmers with a network of vetted buyers and ensure same day payment. Valérie serves as CEO of XpertSea while Sylvie is a vice president. They founded the company with Francois Robitaille and Cody Andrews.

In a statement, Lauren said, “the aquaculture industry is undergoing a massive disruption right now, and XpertSea has the technology and financial solutions to be a leader in this change.”

In conjunction with the financing, Lauren joined Aqua-Spark’s board. Earlier this year, she led QED into Tribal Credit, which is seeking to help small and medium-sized businesses in emerging markets with their financial management.

Prime Movers Lab’s Amy Kruse backs Amanda Feilding’s Beckley Psytech

Prime Movers Lab’s Amy Kruse backs a psychedelic medicine company co-founded by Amanda Feilding and her son, Cosmo Feilding Mellen. Prime Movers took part in Beckley Psytech’s $80 million round, which also included Integrated, Palo Santo, Delphi VC, Leafy Tunnel, Negev Capital and existing investor Bicycle Day Ventures. The Oxford, UK company raised 3 million pounds last year.

Beckley Psytech is focused on developing a pipeline of psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases. It will use the proceeds from the latest financing to complete the ongoing Phase 1b trial with low-dose psilocybin in patients suffering from SUNHA, a rare and debilitating headache condition. Beckley has a strategic partnership with the Beckley Foundation, which was founded by Amanda. A non-profit NGO, the Beckley Foundation has been advancing scientific research into psychedelic medicine for the past 20 years. In a statement, Amy said, “it is nearly impossible to find a team with more experience in developing psychedelic medicines for neurological conditions than the one at Beckley Psytech. The COVID-19 pandemic brought mental health to the public’s attention in a profound way. The excitement around psychedelics in the mental health market is very real because they are transformative medicines that will soon make their way into the lives of millions of people who desperately need them.”

In 2021 Amy has also backed Paradromics, which is developing technology to help physically disabled patients reconnect with the outside world, and Gilgamesh Pharmaceuticals, which is utilizing psychedelic-related medicines for the treatment of neuropsychiatric conditions. She joined Prime Movers Lab last fall as a partner and principal biologist. Amy had previously been the chief scientific officer at Optios, an applied neuroscience company. She also served as the vice president and chief technology officer at Cubic Global Defense and as a government civilian program manager at the Defense Advanced Research Projects Agency where she created its first performance-oriented neuroscience programs. Prime Movers earlier this year closed its second fund at $245 million. The Jackson, Wyo. Firm focuses on backing breakthrough scientific startups.   

U.S. Venture PartnersDafina Toncheva re-invests in Carrot Fertility

U.S. Venture PartnersDafina Toncheva re-invests in Carrot Fertility, a provider of global fertility benefits for employers whose founders include Tammy Sun, Dr. Asima Ahmad and Juli Insinger. USVP took part in the San Francisco company’s $75 million Series C round along with Tiger Global, OrbiMed and fellow existing investors F-Prime Capital, CRV and Silicon Valley Bank.

Previously, Stephanie Palmeri brought Uncork Capital into Carrot while still a partner at the firm and Kathleen Utecht, a managing partner with Core Innovation Capital, led her firm into the company. Carrot also has raised capital from such other firms as Precursor Ventures, Maven Ventures, Sound Ventures, Sherpa Ventures, Founders Fund and Y Combinator. Carrot has devised a platform that provides employers with a customizable fertility benefit that fits their budget, while offering employees a better care experience – before, during and after treatments like basic testing, egg freezing and IVF. To date, the company has signed on hundreds of companies, including Box, Snap, Inc. and Peloton. Carrot serves employees in more than 52 countries.

Tammy serves as CEO, while Asima is chief medical officer and Julie is vice president of business development. They founded Carrot with Maxwell Radomsky, who directs engineering, and Arun Venkatesan, who oversees design.

PEAK Membership

PEAK, Falk Marques Group

1188 Contributions
0 Following